Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-26

Clinical Trial Update: Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update reports that a phase 1/phase 2 trial of gemcitabine with Abraxane and dose-escalated radiotherapy for locally advanced unresectable pancreatic cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abraxane (paclitaxel albumin-bound)
  • Gemzar (gemcitabine)

Snippet

Sponsor: Olugbenga Olowokure | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: TERMINATED